| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Revenue | $5.50B | +29.3% |
| Cost of Revenue | $1.72B | +34.8% |
| Gross Profit | $3.78B | +26.9% |
| R&D Expense | $1.42B | +24.3% |
| SG&A Expense | $405.0M | +3.6% |
| Operating Income | -$188.8M | +37.9% |
| Interest Expense | $27.4M | -83.2% |
| Pre-tax Income | -$207.2M | +55.4% |
| Income Tax | $59.8M |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.12B | +13.0% |
| Short-term Investments | $1.52B | +47.6% |
| Accounts Receivable | $2.14B | +72.7% |
| Current Assets | $6.41B | +38.0% |
| Total Assets | $12.25B | +19.6% |
| Current Liabilities | $8.31B | +62.3% |
| Long-term Debt | $3.68B | +14.0% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.98B | +32.0% |
| Investing Cash Flow | -$933.4M | +37.0% |
| Financing Cash Flow | -$806.6M | +26.9% |
| +76.4% |
| Net Income | -$267.0M | +46.5% |
| EPS (Basic) | -$2.71 | +47.7% |
| EPS (Diluted) | -$2.71 | +47.7% |
| Total Liabilities |
| $12.04B |
| +27.1% |
| Stockholders' Equity | $210.0M | -66.9% |